circulating vaccine-derived poliovirus
Managing the risk of circulating vaccine derived poliovirus during the endgame: oral poliovirus vaccine needs
11
The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south south zone; Nigeria, April 2016
9
Emergence and Localized Circulation of a Vaccine Derived Poliovirus in an Isolated Mountain Community in Guangxi, China
7
Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China
7
Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine
13
Excretion of Wild-Type and Vaccine-Derived Poliovirus in the Feces of Poliovirus Receptor-Transgenic Mice
5
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
9
Impact of Exogenous Sequences on the Characteristics of an Epidemic Type 2 Recombinant Vaccine-Derived Poliovirus
6
Modeling the prevalence of immunodeficiency associated long term vaccine derived poliovirus excretors and the potential benefits of antiviral drugs
18
Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine
9
Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001
10
Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria
10
Long-Term Excretion of Vaccine-Derived Poliovirus by a Healthy Child
9
Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease
9
Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model
10
Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame
19
Genomic Analysis of Vaccine Derived Poliovirus Strains in Stool Specimens by Combination of Full Length PCR and Oligonucleotide Microarray Hybridization
9
Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.
5
Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient
12
RESPONSE OF INFANTS TO TRIVALENT POLIOVIRUS VACCINE (SABIN STRAINS)
8